MRKR

Marker Therapeutics Inc.

Price

$1.44

return (12m)

60.70%

p/e

-3.27

p/bv

2.34

DIVIDEND YIELD

0.00%

MRKR price

Marker Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MRKR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

31.51%

3 months

-8.28%

1 year

60.70%

2 years

-59.32%

5 years

-92.42%

10 years

-97.40%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals MRKR

Valuation

P/E

-3.27

Sector 11.05

Industry 9.16

P/BV

2.34

Sector 1.67

Industry 1.87

P/Revenue (PSR)

12.23

Sector 0.87

Industry 0.72

EV/EBITDA

Sector -258.43

Industry -11.92

EV/EBIT

Sector -41.64

Industry -8.31

P/EBITDA

Sector -50.57

Industry -4.66

P/EBIT

Sector -47.02

Industry 0.21

P/Total Assets

1.95

Sector 0.71

Industry 0.59

P/Net Current Assets

2.34

Sector -4.30

Industry -1.33

P/Working Capital

2.34

Sector -4.90

Industry 1.26

EPS

-0.46

Sector 0.92

Industry 1.40

BVPS

0.64

Sector 10.58

Industry 19.73

Efficiency

Gross Margin

100.00%

Sector 43.52%

Industry 64.20%

EBITDA Margin

Sector 0.36%

Industry 0.31%

EBIT Margin

Sector 0.11%

Industry -0.95%

Operating Margin

-100.00%

Sector 5.19%

Industry 10.67%

Net Profit Margins

-100.00%

Sector 2.03%

Industry 3.20%

Asset Turnover

0.00

Sector 0.21

Industry 0.14

Profitability

ROE

-71.63%

Sector 3.15%

Industry 5.09%

ROA

-59.70%

Sector 0.77%

Industry 0.94%

ROIC

0.00%

Sector -4.01%

Industry -

Dividends

Dividend yield

0.00%

Sector 0.30%

Industry 0.70%

Payout

Sector 9.21%

Industry 14.02%

Debt

Current Ratio

6.03

Sector 1.04

Industry 1.11

Net Debt / EBITDA

Sector -111.37

Industry -4.58

Net Debt / EBIT

Sector -17.70

Industry -4.69

Net Debt / Equity

0.00

Sector 0.11

Industry 1.56

Gross Debt / Equity

0.00

Sector 0.27

Industry 1.64

Equity/Assets

0.83

Sector 0.31

Industry 0.45

Liabilities/Assets

0.17

Sector 0.61

Industry 0.60

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-26.95%

Sector -

Industry -

Fundamentals MRKR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MRKR Marker Therapeutics Inc.	$1.44	53.21%	0.00%	-3.27	2.34	-71.63%	-100.00%
V Visa Inc.	$382.85	10.35%	0.68%	28.27	18.15	64.22%	50.78%
PAYX Paychex Inc.	$127.40	-3.39%	3.55%	25.30	11.92	47.12%	27.03%
MCO Moody's Corporation	$515.80	2.19%	0.77%	31.73	28.04	88.38%	34.29%
BKNG Booking Holdings Inc.	$206.90	-6.91%	0.76%	22.68	-15.17	-66.86%	25.53%
ROL Rollins Inc.	$36.30	-34.84%	1.92%	33.54	12.48	37.19%	13.55%
WM Waste Management Inc.	$219.32	-1.33%	1.56%	31.90	9.17	28.75%	11.12%
CPRT Copart Inc.	$33.05	-32.01%	0.00%	20.10	3.55	17.65%	33.39%
RHI Robert Half International Inc.	$45.42	36.15%	5.30%	38.80	3.69	9.51%	2.17%
GMAB Genmab A/S	$33.32	34.46%	0.00%	25.69	3.40	13.23%	19.08%
WMG Warner Music Group Corp.	$28.10	-15.11%	2.74%	21.83	15.23	69.78%	9.10%
FLT Fleetcor Technologies Inc.	$0.00	-	0.00%	19.65	5.88	29.91%	26.13%
EFX Equifax Inc.	$195.20	-19.57%	1.09%	32.89	5.21	15.83%	10.80%
TTEK Tetra Tech Inc.	$36.64	0.51%	0.73%	21.73	5.12	23.57%	8.61%
EXLS ExlService Holdings Inc.	$38.18	-12.39%	0.00%	23.05	6.65	28.86%	11.17%
PKOH Park-Ohio Holdings Corp.	$46.21	139.87%	1.12%	25.93	1.60	6.17%	1.46%
VSEC VSE Corporation	$215.54	30.90%	0.19%	88.77	2.27	2.56%	5.53%
HCSG Healthcare Services Group Inc.	$22.35	43.45%	0.00%	12.80	3.03	23.70%	8.80%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MRKR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Marker Therapeutics

Marker Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

34 years

Founded: 1992

1998

Time since IPO - 28 years

8

Employees

Marker Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $28.50 million, with shareholders equity totaling $12.16 million.

The company employs approximately 8 people and operates in the Services sector, within the Commercial Services industry.

Over the past 12 months, Marker Therapeutics Inc. reported $2.33 million in revenue, generating net income of $-8.71 million.

Key financial metrics include a P/E ratio of -3.27, a price-to-book (P/B) ratio of 2.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MRKR.

Market cap

$28.50 million

Net worth

$12.16 million

$12,160,000.00

Assets

$14.59 million

$14,590,000.00

Total Shares Outstanding

19.00 million

19,000,000

Average Daily Trading Volume

$66.02 Thousand

$66,018.34

Sector

Services

Industry

Commercial Services

MRKR

MRKR revenue and profits

Financial Results MRKR

DRAG THE FRAME TO SEE MORE DATA

MRKR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

AMZN - Amazon

$266.85 18,42% (12M)

P/E

21.04

0.00%

ROE

24.52%

P/BV

5.16

WMT - Walmart

$102.99 7,60% (12M)

P/E

36.53

0.91%

ROE

22.96%

P/BV

8.39

COST - Costco Wholesale

$950.78 1,38% (12M)

P/E

48.80

0.57%

ROE

26.38%

P/BV

12.87

KR - Kroger

$57.86 --13,79% (12M)

P/E

34.56

2.39%

ROE

16.12%

P/BV

5.57

JD - JD.com

$28.64 --4,68% (12M)

P/E

23.04

2.98%

ROE

4.80%

P/BV

1.11

HD - Home Depot

$328.76 --16,45% (12M)

P/E

23.77

2.76%

ROE

100.99%

P/BV

24.01

BABA - Alibaba

$118.70 --12,07% (12M)

P/E

26.21

0.89%

ROE

6.42%

P/BV

1.68

WBA - Walgreens Boots Alliance

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-83.97%

P/BV

0.00